Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
As Healio previously reported, the FDA removed tirzepatide (Mounjaro/Zepbound, Eli Lilly) and semaglutide (Ozempic/Wegovy, Novo Nordisk) from its drug shortage list in 2024 and 2025, respectively, and now prohibits both 503A compounding pharmacies and 503B outsourcing facilities from distributing compounded versions of the drug
Repairs Damaged Skin - Restores skin barrier and improves overall smoothness
Hormonal Shifts Semaglutide modifies insulin secretion and glucagon equilibrium, and fluctuations in these hormones can influence skin aging indirectly
Common local reactions include: Some patients report less nausea when injecting in the thigh compared to the abdomen
Staying abreast of potential side effects, understanding the nuances of the new prescription, and accessing support from healthcare specialists can help patients lead their way through the transition week by week
